HCPCS drug code · CMS crosswalk
Glycopyrrolate Injection J-Code / HCPCS Code
In short
CMS assigns Glycopyrrolate Injection NDCs to 2 HCPCS codes: J1596 (per 0.1 mg), J1598 (per 0.1 mg). Which one applies depends on the product; the table lists each NDC with its code.
Reference
- J1596
- Injection, glycopyrrolate, 0.1 mgBilling unit: 0.1 mg
- J1598
- Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mgBilling unit: 0.1 mg
- Labelers
- A-S Medication Solutions; Alembic Pharmaceuticals Inc.; American Regent, Inc.; Amneal Pharmaceuticals, LLC; Apotex Corp; Athenex Pharmaceutical Division, LLC; BE Pharmaceuticals Inc.; Civica, Inc.and 10 more
Medicare Part B payment limit
CMS ASP filePayment limit per unit$0.33
Per0.1 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Medicare Part B payment limit
CMS ASP filePayment limit per unit$1.904
Per0.1 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Glycopyrrolate Injection units and claim line
Enter the dose given to get the J1596 units and the NDC line for the CMS-1500 and the 837P. This builds the J1596 line; use the code page for J1598.
Enter the dose given to build the claim line.
Glycopyrrolate Injection NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9584-10 | J1596 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 400 |
| 00143-9585-25 | J1596 | Hikma Pharmaceuticals USA Inc. | 25 × 5 | 250 |
| 00143-9586-25 | J1596 | Hikma Pharmaceuticals USA Inc. | 25 × 2 | 100 |
| 00143-9587-25 | J1596 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 50 |
| 00143-9679-10 | J1596 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 400 |
| 00143-9680-25 | J1596 | Hikma Pharmaceuticals USA Inc. | 25 × 5 | 250 |
| 00143-9681-25 | J1596 | Hikma Pharmaceuticals USA Inc. | 25 × 2 | 100 |
| 00143-9682-25 | J1596 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 50 |
| 00404-9775-01 | J1596 | Henry Schein Inc. | 1 | 2 |
| 00404-9776-05 | J1596 | Henry Schein Inc. | 5 | 10 |
| 00404-9777-20 | J1596 | Henry Schein Inc. | 20 | 40 |
| 00404-9782-02 | J1596 | Henry Schein Inc. | 2 | 4 |
| 00404-9867-01 | J1596 | Henry Schein Inc. | 1 | 2 |
| 00404-9868-20 | J1596 | Henry Schein Inc. | 20 | 40 |
| 00404-9869-02 | J1596 | Henry Schein Inc. | 2 | 4 |
| 00404-9870-05 | J1596 | Henry Schein Inc. | 5 | 10 |
| 00517-4601-25 | J1596 | American Regent, Inc. | 25 × 1 | 50 |
| 00517-4602-25 | J1596 | American Regent, Inc. | 25 × 2 | 100 |
| 00517-4605-25 | J1596 | American Regent, Inc. | 25 × 5 | 250 |
| 00517-4620-25 | J1596 | American Regent, Inc. | 25 × 20 | 1000 |
| 00641-6212-10 | J1596 | Hikma Pharmaceuticals USA Inc. | 10 × 1 | 20 |
| 00641-6213-10 | J1596 | Hikma Pharmaceuticals USA Inc. | 10 × 2 | 40 |
| 00781-3825-96 | J1596 | Sandoz Inc. | 25 × 1 | 50 |
| 00781-3827-96 | J1596 | Sandoz Inc. | 25 × 2 | 100 |
| 00781-3829-96 | J1596 | Sandoz Inc. | 25 × 5 | 250 |
| 00781-3831-95 | J1596 | Sandoz Inc. | 10 × 20 | 400 |
| 25021-0796-01 | J1596 | Sagent Pharmaceuticals | 25 × 1 | 50 |
| 25021-0796-02 | J1596 | Sagent Pharmaceuticals | 25 × 2 | 100 |
| 25021-0796-05 | J1596 | Sagent Pharmaceuticals | 25 × 5 | 250 |
| 50090-4513-00 | J1596 | A-S Medication Solutions | 1 | 2 |
| 50090-5226-00 | J1596 | A-S Medication Solutions | 25 × 1 | 50 |
| 51662-1487-01 | J1596 | HF Acquisition Co. LLC, DBA HealthFirst | 1 | 2 |
| 51662-1487-03 | J1596 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 1 | 50 |
| 51662-1554-03 | J1596 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 2 | 100 |
| 51662-1601-01 | J1596 | HF Acquisition Co. LLC, DBA HealthFirst | 5 | 10 |
| 51662-1601-03 | J1596 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 5 | 250 |
| 60505-6179-05 | J1596 | Apotex Corp | 25 × 1 | 50 |
| 60505-6180-05 | J1596 | Apotex Corp | 25 × 2 | 100 |
| 60505-6181-05 | J1596 | Apotex Corp | 25 × 5 | 250 |
| 60505-6182-04 | J1596 | Apotex Corp | 10 × 20 | 400 |
| 62332-0607-25 | J1596 | Alembic Pharmaceuticals Inc. | 25 × 1 | 50 |
| 62332-0627-25 | J1596 | Alembic Pharmaceuticals Inc. | 25 × 2 | 100 |
| 62332-0628-25 | J1596 | Alembic Pharmaceuticals Inc. | 25 × 5 | 250 |
| 62332-0629-10 | J1596 | Alembic Pharmaceuticals Inc. | 10 × 20 | 400 |
| 63323-0578-01 | J1596 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| 63323-0578-02 | J1596 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| 63323-0578-05 | J1596 | FreseniUS Kabi USA, LLC | 25 × 5 | 250 |
| 63323-0578-11 | J1596 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| 63323-0578-12 | J1596 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| 65219-0801-01 | J1596 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| 66794-0202-42 | J1596 | Piramal Critical Care Inc | 25 × 1 | 50 |
| 66794-0203-42 | J1596 | Piramal Critical Care Inc | 25 × 2 | 100 |
| 66794-0204-42 | J1596 | Piramal Critical Care Inc | 25 × 5 | 250 |
| 66794-0205-41 | J1596 | Piramal Critical Care Inc | 10 × 20 | 400 |
| 70069-0616-10 | J1596 | Somerset Pharma, LLC | 10 × 20 | 400 |
| 70069-0617-25 | J1596 | Somerset Pharma, LLC | 25 × 1 | 50 |
| 70069-0618-25 | J1596 | Somerset Pharma, LLC | 25 × 2 | 100 |
| 70069-0619-25 | J1596 | Somerset Pharma, LLC | 25 × 5 | 250 |
| 70121-1698-07 | J1596 | Amneal Pharmaceuticals, LLC | 10 × 1 | 20 |
| 70121-1699-07 | J1596 | Amneal Pharmaceuticals, LLC | 10 × 2 | 40 |
| 70700-0165-25 | J1596 | Xiromed, LLC | 25 × 1 | 50 |
| 70700-0166-25 | J1596 | Xiromed, LLC | 25 × 2 | 100 |
| 70700-0167-25 | J1596 | Xiromed, LLC | 25 × 5 | 250 |
| 70700-0168-23 | J1596 | Xiromed, LLC | 10 × 20 | 400 |
| 70700-0902-25 | J1596 | Xiromed, LLC | 25 × 5 | 250 |
| 70700-0903-23 | J1596 | Xiromed, LLC | 10 × 20 | 400 |
| 70860-0781-01 | J1596 | Athenex Pharmaceutical Division, LLC | 25 × 1 | 50 |
| 70860-0781-02 | J1596 | Athenex Pharmaceutical Division, LLC | 25 × 2 | 100 |
| 70860-0781-05 | J1596 | Athenex Pharmaceutical Division, LLC | 25 × 5 | 250 |
| 70860-0781-20 | J1596 | Athenex Pharmaceutical Division, LLC | 10 × 20 | 400 |
| 71288-0414-03 | J1596 | Meitheal Pharmaceuticals Inc. | 25 × 1 | 50 |
| 71288-0414-04 | J1596 | Meitheal Pharmaceuticals Inc. | 25 × 2 | 100 |
| 71288-0414-92 | J1596 | Meitheal Pharmaceuticals Inc. | 25 × 1 | 50 |
| 71288-0414-94 | J1596 | Meitheal Pharmaceuticals Inc. | 25 × 2 | 100 |
| 71288-0415-06 | J1596 | Meitheal Pharmaceuticals Inc. | 25 × 5 | 250 |
| 71288-0415-21 | J1596 | Meitheal Pharmaceuticals Inc. | 10 × 20 | 400 |
| 71288-0415-96 | J1596 | Meitheal Pharmaceuticals Inc. | 25 × 5 | 250 |
| 71839-0123-25 | J1596 | BE Pharmaceuticals Inc. | 25 × 1 | 50 |
| 71839-0124-25 | J1596 | BE Pharmaceuticals Inc. | 25 × 2 | 100 |
| 71839-0125-25 | J1596 | BE Pharmaceuticals Inc. | 25 × 5 | 250 |
Glycopyrrolate Injection: common questions
- What is the J-code for Glycopyrrolate Injection?
- CMS assigns Glycopyrrolate Injection NDCs to 2 HCPCS codes: J1596 (per 0.1 mg), J1598 (per 0.1 mg). Which one applies depends on the product; the table lists each NDC with its code.
- How many J1596 billing units are in a package of Glycopyrrolate Injection?
- CMS lists 2 to 1,000 billing units per package, depending on the NDC, where one unit is 0.1 mg. Units to report are based on the dose given, not the package.
- How many J1598 billing units are in a package of Glycopyrrolate Injection?
- CMS lists 60 billing units per package, depending on the NDC, where one unit is 0.1 mg. Units to report are based on the dose given, not the package.
- Is J1596 a CPT code?
- No. J1596 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.